Shell Asset Management Co. Decreases Stake in GE HealthCare Technologies Inc. $GEHC

Shell Asset Management Co. cut its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 35.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,548 shares of the company’s stock after selling 7,959 shares during the period. Shell Asset Management Co.’s holdings in GE HealthCare Technologies were worth $1,093,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. True North Advisors LLC boosted its holdings in shares of GE HealthCare Technologies by 2.0% during the 3rd quarter. True North Advisors LLC now owns 6,987 shares of the company’s stock valued at $525,000 after acquiring an additional 139 shares during the last quarter. Klingman & Associates LLC raised its holdings in shares of GE HealthCare Technologies by 4.0% during the third quarter. Klingman & Associates LLC now owns 3,634 shares of the company’s stock valued at $273,000 after purchasing an additional 139 shares during the last quarter. Golden State Wealth Management LLC lifted its position in GE HealthCare Technologies by 7.4% during the second quarter. Golden State Wealth Management LLC now owns 2,138 shares of the company’s stock valued at $158,000 after purchasing an additional 148 shares during the period. Exchange Traded Concepts LLC boosted its holdings in GE HealthCare Technologies by 1.3% in the third quarter. Exchange Traded Concepts LLC now owns 11,490 shares of the company’s stock worth $863,000 after purchasing an additional 150 shares during the last quarter. Finally, Modera Wealth Management LLC boosted its holdings in GE HealthCare Technologies by 3.5% in the second quarter. Modera Wealth Management LLC now owns 4,500 shares of the company’s stock worth $333,000 after purchasing an additional 152 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Price Performance

NASDAQ GEHC opened at $80.34 on Monday. The business’s fifty day moving average is $82.44 and its 200 day moving average is $77.66. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $93.26. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37. The company has a market capitalization of $36.61 billion, a PE ratio of 17.62, a price-to-earnings-growth ratio of 1.77 and a beta of 1.09.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, topping the consensus estimate of $1.40 by $0.04. The firm had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The business’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same quarter last year, the company earned $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio is presently 3.07%.

Analyst Ratings Changes

GEHC has been the topic of several research analyst reports. The Goldman Sachs Group reissued a “buy” rating and set a $98.00 price target on shares of GE HealthCare Technologies in a report on Friday, January 9th. Wells Fargo & Company upped their price objective on GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Evercore increased their target price on GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Barclays raised their target price on GE HealthCare Technologies from $86.00 to $87.00 and gave the stock an “equal weight” rating in a research report on Friday, February 6th. Finally, Stifel Nicolaus upped their price target on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company a “buy” rating in a research report on Wednesday, February 4th. Seven investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $92.50.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.